KitoTech Medical has formed a partnership and signed an exclusive agreement with Corza Medical, a leading global manufacturer of innovative surgical technologies, giving it the right to market and sell the microMend® family of wound closure products in the medical and surgical markets in the United States. ​

Treating a child presents a unique challenge for healthcare providers. Without thoughtful, sensitive treatment focused on the unique needs of the pediatric patient population, urgent care providers risk dissatisfied patients, decreased patient outcomes, and delayed patient care.

Cuts and lacerations are among the most common complaints that bring patients to urgent care clinics. Whether a wound originates from an accident with a sharp object, such as a kitchen knife or yard tool, or from a blunt force such as a fall, there may be a risk of infection. 

There are a number of factors that can impact patient satisfaction, including the courtesy and respect patients feel while in the care facility, the clarity of the information provided, and urgent care wait times.

Dermatologists may perform a number of in-office procedures that result in wounds, including biopsies and mole excisions. Traditional options for repairing these wounds include sutures, staples, adhesive strips, and other suture types. However, traditional wound care methods have several drawbacks, including cost, time, and patient limitations.

KitoTech Medical, a Seattle-based medical device company, announced today that it has completed the first close of approximately $2M of its Series B Round where there is the potential to raise a total of $6M. The proceeds from the financing will be primarily used to increase KitoTech’s commercial efforts in the medical market to increase the use of and drive sales of its microMend® family of wound closure products. The funding will also be used to increase sales of our consumer products by expanding into additional channels.
​
The funds will be used to build KitoTech’s medical sales organization to market and sell microMend products to increasing numbers of physicians, hospitals, and clinics. In addition, the financing will provide the resources to allow KitoTech to introduce its products into a broad spectrum of clinical specialties, including orthopedics, obstetrics and gynecology, and surgery. The financing will also provide support for commercial activities in the consumer market, where there has been rapid sales growth since introducing microMend products last year. 

“microMend has shown outstanding results and is being adopted by several leading hospitals and healthcare systems throughout the US. With the new Series B Round funding, KitoTech will have the capacity to reach out to many more physicians and hospitals where they will have the opportunity to experience the clinical and economic benefits of our microMend products. In addition, we are pleased that more patients will be able to achieve better wound closure results that include less scarring than with traditional products,” says Dr. Ronald Berenson, President and CEO of KitoTech Medical. “In addition, we have witnessed extraordinary sales growth of our microMend products in the consumer market. With support from this financing, we will expand our  efforts to provide new product offerings as well as additional channels for consumers to purchase our products.” 

KitoTech Medical, a medical device company, announces the addition of the microMend® Variety Pack to its growing line of consumer skin closure products. The new product contains three different microMend Skin Closure device sizes, all designed for easy application by consumers. This unique product combination allows them to close most lacerations quickly and easily, whether at home or away.  
 
With its broad range of skin closure devices, the microMend Variety Pack addresses the need to treat wounds of a variety of sizes. Each Variety Pack has a total of five (5) devices including a new device that closes a laceration of 1” in width; two medium-sized devices, ideal for closing most small lacerations; and two narrow devices, perfect for closing smaller lacerations on the fingers, ears and areas around the nose and mouth. All five devices can be used together to close wounds up to 2 ½” in length.
 
“We are excited to introduce the new microMend Variety Pack to provide consumers with a family of products that can be used to treat nearly all lacerations from the smallest on the fingers to larger wounds on the arms, legs, and other areas of the body. KitoTech is committed to developing wound closure products that meet the growing demand for consumers to treat themselves rather than visiting busy and expensive ERs and Urgent Care Clinics,” said Dr. Ron Berenson, President and CEO of KitoTech Medical.

KitoTech Medical, manufacturer of microMend® Skin Closure devices, announces that it exhibited at the recent American College of Emergency Physicians (ACEP) Scientific Assembly 2021 in Boston, MA. Hundreds of physicians and other front-line emergency medical personnel visited KitoTech’s exhibition booth, where they were provided with information and demonstrations of microMend’s five wound closure products. The product portfolio includes a range of device sizes that allow healthcare providers to close most lacerations, skin tears, and other wounds.  
​
“It was exciting to once again have the opportunity to share our innovative approach to wound closure at ACEP”, said David Krall, Vice President of Sales and Marketing at KitoTech. “We thank the many clinicians who visited our exhibit booth to learn more about microMend and its applications in the emergency department. Many were shown how to use the devices and were impressed with how easy they are to use and their ability to provide faster closure, lower costs and a high level of patient satisfaction!” Krall added. 

microMend can close wounds in a fraction of the time required for sutures, as the application is as fast and easy as using a bandage and since it is painless there is no need for local anesthesia. This time saving translates into significant cost savings and is a major benefit in busy ERs and Urgent Care Clinics. Patients can remove microMend themselves eliminating the return clinic visit usually required to remove sutures which is inconvenient and time consuming for patients and busy healthcare providers. The device is especially attractive for use with children, where the easy and painless application and removal are major advantages over sutures. In addition, microMend is effective in closing lacerations and skin tears in those with fragile skin including the elderly and chronically ill that are difficult to treat with other products.